Literature DB >> 10859422

Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance.

M Morena1, J P Cristol, B Canaud.   

Abstract

Oxidative stress which results from an imbalance between reactive oxygen species production and antioxidant defense mechanisms is now well recognized in hemodialysis (HD) patients and could be involved in dialysis-related pathologies such as accelerated atherosclerosis, amyloidosis and anemia. In order to evaluate the rationale for preventive intervention against oxidative damage during HD, we review the factors that are implied and may be responsible for the imbalance between pro- and antioxidative mechanisms. The inflammatory state mainly due to hemobioincompatibility of the dialysis system plays a critical role in the production of free oxygen radical species contributing by this way to worsen the prooxidant status of uremic patients. Two factors largely contribute to the stimulation of the NADPH oxidase: hemoreactivity of the membrane and trace amounts of endotoxins. The antioxidant system is severely impaired in uremic patients and gradually altered with the degree of renal failure. HD could further impair this antioxidant system mainly by losses of (a) hydrophilic unbound small-molecular-weight substances such as vitamin C, (b) trace elements and (c) enzyme-regulatory compounds. Two main axes may be proposed in order to prevent and/or to decrease oxidative stress in HD patients. One consists in improving the hemocompatibility of the dialysis system mainly by using a dialyzer with low hemoreactivity and ultrapure, sterile, nonpyrogenic dialysate. The other consists in supplementing the deficiency patients with antioxidants. This could be achieved by oral or perdialytic supplementation. Vitamin E could be bound on dialyzer membrane. Alternatively, hemolipodialysis consists in loading HD patients with vitamin C or E via an ancillary circuit made of vitamin E-rich liposomes. The presence of liposomes could also facilitate the removal of hydrophobic prooxidative substances. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859422     DOI: 10.1159/000014418

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  9 in total

1.  Correlations of cardiac function with inflammation, oxidative stress and anemia in patients with uremia.

Authors:  Heping Zhang; Lei Fan; Huawei Liao; Lirong Tu; Jie Zhang; Dan Xu; Jiangchao Feng
Journal:  Exp Ther Med       Date:  2021-01-22       Impact factor: 2.447

Review 2.  Anthocyanins-rich interventions on oxidative stress, inflammation and lipid profile in patients undergoing hemodialysis: meta-analysis and meta-regression.

Authors:  Isabelle C V S Martins; Michel G Maciel; José L M do Nascimento; Denise Mafra; Alexsandro F Santos; Camila S Padilha
Journal:  Eur J Clin Nutr       Date:  2022-07-12       Impact factor: 4.884

3.  Effect of hemodialysis on traditional and innovative cardiac markers.

Authors:  Martina Montagnana; Giuseppe Lippi; Nicola Tessitore; Gian Luca Salvagno; Giovanni Targher; Matteo Gelati; Antonio Lupo; Gian Cesare Guidi
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

4.  Oxidative stress markers and C-reactive protein in end-stage renal failure patients on dialysis.

Authors:  Elisabeth C Samouilidou; Eirini J Grapsa; Ioannis Kakavas; Antonios Lagouranis; Basilis Agrogiannis
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

5.  The relationships between exogenous and endogenous antioxidants with the lipid profile and oxidative damage in hemodialysis patients.

Authors:  Miguel Roehrs; Juliana Valentini; Clóvis Paniz; Angela Moro; Mariele Charão; Rachel Bulcão; Fernando Freitas; Natália Brucker; Marta Duarte; Mirna Leal; Geni Burg; Tilman Grune; Solange Cristina Garcia
Journal:  BMC Nephrol       Date:  2011-10-26       Impact factor: 2.388

6.  Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients.

Authors:  María Jesús Izquierdo; Mónica Cavia; Pilar Muñiz; Angel L M de Francisco; Manuel Arias; Javier Santos; Pedro Abaigar
Journal:  BMC Nephrol       Date:  2012-11-27       Impact factor: 2.388

7.  Role of plasma protein and low-molecular weight substances in the change of hydroxyl radical scavenging activity in hemodialysis patients.

Authors:  Akiko Hirakawa; Kazumasa Aoyagi; Motoo Nakajima; Syuichi Kikuchi; Syoji Ohba; Kunihiro Yamagata
Journal:  J Clin Biochem Nutr       Date:  2008-03       Impact factor: 3.114

8.  Total and corrected antioxidant capacity in hemodialyzed patients.

Authors:  Niki Malliaraki; Dimitris Mpliamplias; Marilena Kampa; Kostas Perakis; Andrew N Margioris; Elias Castanas
Journal:  BMC Nephrol       Date:  2003-07-01       Impact factor: 2.388

Review 9.  Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review.

Authors:  Konstantina P Poulianiti; Antonia Kaltsatou; Georgia I Mitrou; Athanasios Z Jamurtas; Yiannis Koutedakis; Maria Maridaki; Ioannis Stefanidis; Giorgos K Sakkas; Christina Karatzaferi
Journal:  Oxid Med Cell Longev       Date:  2016-08-03       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.